ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Brammer Bio expands capacity

by Marc S. Reisch
October 2, 2017 | APPEARED IN VOLUME 95, ISSUE 39

[+]Enlarge
Credit: Brammer Bio
Brammer Bio is expanding its facilities.
Credit: Brammer Bio
Brammer Bio is expanding its facilities.

Brammer Bio has undertaken expansions at its early-clinical-phase facility in Alachua, Fla., and its Phase III and commercial facility in Cambridge, Mass. Investments at the two facilities total $40 million and include a range of Pall Life Sciences bioreactors to bolster cell and gene therapy manufacturing.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment